Neutrophils release reactive oxygen species (ROS) as part of the innate inflammatory immune response. Phosphoinositide 3-kinase γ (PI3Kγ ), which is induced by the bacterial peptide Nformylmethionyl-leucyl-phenylalanine (fMLP), has been identified as an essential intracellular mediator of ROS production. However, the complex signalling reactions that link PI3Kγ with ROS synthesis by NADPH oxidase have not yet been described in detail. We found that activation of neutrophils by fMLP triggers the association of PI3Kγ with protein kinase Cα (PKCα). Specific inhibition of PI3Kγ suppresses fMLP-mediated activation of PKCα activity and ROS production, suggesting that the protein kinase activity of PI3Kγ is involved. Our data suggest that the direct interaction of PI3Kγ with PKCα forms a discrete regulatory module of fMLP-dependent ROS production in neutrophils.
INTRODUCTION
Neutrophils are key mediators of innate immunity and host defence. After exposure to chemotaxins, freely circulating neutrophils adhere to endothelial cells and migrate into infected tissue. Once they have reached the inflamed area, the neutrophils begin to phagocytose the pathogens. Secretion of reactive oxygen species (ROS) and lysosomal enzymes contributes to the killing of bacteria. Neutrophil defence reactions are tightly controlled by inflammatory mediators, including chemokines, bacterial peptides and complement fragments.
Bacterial cell wall-derived chemotactic peptides, such as N-formylmethionyl-leucyl-phenylalanine (fMLP) or complement fragment C5a, are prototypical peptides that affect the cell responses of neutrophils by binding to specific G-protein-coupled receptors [1] . The interactions of these chemotaxins with their receptors trigger multiple intracellular signalling pathways, including rapid stimulation of phosphoinositide 3-kinase γ (PI3Kγ ) [2, 3] . This signalling protein plays a critical role in the control of neutrophil migration and ROS secretion induced by fMLP and chemokines [4] [5] [6] . In neutrophils and other cell types, PI3Kγ exists in a heterodimeric form associated with the adapter protein p101. p101 strongly enhances G-proteindependent stimulation of the lipid kinase activity of PI3Kγ in vitro [7] . Comparative investigations have revealed a substantial decrease in PI3Kγ lipid kinase activity and PtdIns(3,4,5)P 3 production provoked by chemoattractants in p101 −/− neutrophils in comparison with wild-type littermates. In addition, simultaneous loss of chemoattractant-dependent migration has been observed in p101-deficient neutrophils. In compelling contrast with these findings, p101 −/− neutrophils exhibit an unaltered oxidative burst induced by fMLP or C5a [8] .
These intriguing data point to differential functions for p101 in migration and chemoattractant-induced ROS production of neutrophils. Whereas migration of neutrophils requires interactions between p101 and PI3Kγ , ROS production induced by chemoattractants appears to be independent of p101. Consequently, the distinct regulatory effects of PI3Kγ on both inflammatory reactions of neutrophils become apparent.
The present study provides, to our knowledge, the first evidence of a PI3Kγ -dependent signalling path for ROS production that does not involve the lipid kinase activity of the signalling protein.
Our data reveal the interactions of PI3Kγ with protein kinase Cα (PKCα) and p47phox in human neutrophils induced by fMLP. Chemoattractant-induced binding of PI3Kγ to PKCα coincides with ROS production and is accompanied by a significant increase in PKCα activity. The functional relevance of the proposed PI3Kγ -PKCα signalling pathway will be discussed.
Germany). The HEK293 cell-line which stably expresses the catalytic subunit p110γ was from our laboratory collection.
Recombinant proteins
For recombinant protein production, the PKCα-encoding gene was amplified by PCR using primers PKC-FW, containing an EcoRI restriction site (underlined) (5 -GCUGAATTCU-GGCATGGCTGACGTTTTCCCGGGC-3 ), and PKCα-REV, containing an XbaI restriction site (underlined) (5 -TGCU-TCTAGAUATCATACTGCACTCTGTAAGATGGGG-3 ). The amplifed gene was subsequently subcloned into plasmid pcDNA [9] . In parallel, a DNA region encoding the GST (glutathione transferase) epitope was amplified using primer GST-FW, containing a BamHI restriction site (underlined) (5 -CGUGGATCCUGGCATGTCCCCTATACTAGG-3 ), and GST-REV, containing an EcoRI restriction site (underlined) (5 -GAUGAATTCAUGAACGCGGAACCAGATCCGA-3 ). To produce GST-PKCα, the subcloned DNA fragments were fused and inserted into pFastBac1 (Invitrogen, Karlsruhe, Germany). The resulting plasmid pFastBac1-GST-PKCα was chemically transformed into Escherichia coli DH10BacTM cells and integrated by site-specific recombination into bacmids containing the host DNA. GST-PKCα-Bacmid was transfected into Sf9 cells, and baculoviruses were produced in accordance with the manufacturer's instructions. The baculovirus Sf9 system was used to produce the recombinant proteins PKCα, GST-PKCα, and His-tagged wild-type PI3Kγ or catalytically inactive PI3Kγ -K799R [10] , as described previously [11] . Recombinant p47phox and p67phox proteins were produced in E. coli as described previously [12] . GST-tagged proteins were purified by affinity chromatography on glutathione-agarose. Subsequently, the GST epitope was cleaved using thrombin.
Affinity precipitation of recombinant proteins
Purified recombinant proteins (1 μg each) were incubated in kinase buffer for 30 min at 30
• C. Subsequently, epitope-labelled proteins were purified using affinity purification. His-PI3Kγ was purified using Ni-NTA (Ni 2+ -nitrilotriacetate)-agarose and GST-PKCα was purified using glutathione beads. Affinity chromatography material (50 μl slurry) was incubated for 1 h with ongoing agitation. Beads were washed extensively at least four times. For purification of His-PI3Kγ , imidazole (20 mM) was added to the buffer to reduce non-specific binding. Affinitypurified material was boiled in protein loading buffer and directly subjected to SDS-PAGE.
Kinase assays
Protein kinase assays using purified His-PI3Kγ proteins and GST-PKCα protein were carried out at 30
• C as described by Stoyanova et al. [10] . PMA (300 nM), BIM (100 nM), wortmannin (100 nM), or liposomes were added to the reaction mixture. Lipids (100 mM total lipid) were composed of diacylglycerol (DAG)/PtdIns(3,4,5)P 3 /phosphatidylserine/phosphatidylcholine (5:10:40:45 mol/mol). Specific PKCα activity was determined using calf thymus histone H1 or p47phox as a substrate (total amount, 0.1 μg/ml) in the presence of 5 μCi of [γ -32 P]ATP and incubation at 30 • C. In vivo activity of PKCα was determined from freshly prepared neutrophils. PKCα was immunoprecipitated from lysates of 3 × 10 7 cells and subsequently used for kinase assays. Reaction mixtures (25 μl) were subjected to SDS/PAGE on 12.5 % polyacrylamide gels. After electrophoresis, the gels were washed three times to remove unincorporated ATP and subsequently exposed to P-image analysis. The amount of incorporated 32 P was quantified using a phospho-imaging system (FLA500, Fuji, Raytest) and AIDA image analysis software. Differences were considered significant at P < 0.05.
Mass spectrometric analysis
Protein gels were stained with Coomassie Brillant Blue R250 (Sigma) and appropriate gel sections were subjected to in-gel digestion with trypsin as described by Shevchenko et al. [13] with one modification: reduction and oxidation of thiol groups was performed with a mixture of 0.1 mM tributylphosphine (SigmaAldrich, Taufkirchen, Germany) and 0.82 mM 4-vinylpyridine (Sigma-Aldrich). The trypsin in-gel protein digests were analysed with LC-ESI-MS equipment consisting of an Ettan micro LC-HPLC (GE Healthcare, Munich, Germany) online coupled to a Finnigan LTQ (linear trap quadrupole) mass spectrometer (Thermo Electron Corporation, Erlangen, Germany). The HPLC was equipped with a Zorbax 300SB 5 μM, 5 × 0.3 mm trapping column and a Zorbax 300SB 5 μM, 150 × 0.075 mm separation column (Agilent, Böblingen, Germany). The separation of peptides on the HPLC occurred by applying a linear gradient running from 0 % to 47 % acetonitrile, followed by a stepwise elution with 84 % acetonitrile in 0.1 % formic acid, each under control of Unicorn software (GE Healthcare, Munich, Germany). The LTQ was operated under control of Xcalibur 1.4 software (Thermo Electron Corporation, Erlangen, Germany). For processing of the collision-induced dissociation spectra (MS/MSspectra) and final protein identification, BioWorks 3.2 software (Thermo Electron Corporation, Erlangen, Germany) and the National Center for Biotechnology Information human protein database were used. Site-specific phosphorylation analysis was performed by scanning pSer and pThr for loss of phosphoric acid (neutral loss of 98) in the respective MS/MS spectra.
Preparation of neutrophils
Human neutrophils were isolated from peripheral blood from healthy volunteers. The erythrocytes were removed by dextran sedimentation and the samples were then loaded on a Histopaque gradient to exclude lymphocytes, monocytes and platelets. Any remaining erythrocytes were removed by hypotonic lysis in distilled water. Finally, the cells were washed twice with PBS and resuspended in the appropriate buffers. Trypan Blue staining revealed that at least 95 % of the cells were neutrophils with greater than 95 % viability.
Neutrophil stimulation and treatment with inhibitors
Freshly prepared neutrophils were incubated at 37
• C in resuspension buffer (30 mM Hepes, 110 mM NaCl, 10 mM KCl, 1 mM MgCl 2 , 1.5 mM CaCl 2 , 10 % glycerol and 0.5 mg/ml BSA). If indicated, inhibitors (10 μM AS605240 and 1 μM BIM) were added 30 min before stimulation. Cells were stimulated with 1 μM fMLP for the indicated time periods at 37
• C and stopped by rapid, short centrifugation at 4
• C.
Preparation of membrane and cytosolic fractions
Human neutrophils were isolated as described, aliquoted (3 × 10 7 cells) in resuspension buffer and stimulated. Cells were then rebuffered in fractionation buffer (25 mM Hepes, 25 mM β-glycerophosphate, 2 mM EDTA, 0.5 mg/ml BSA, 1 mM Na 3 VO 4 , 1 mM PMSF, 21 μg/ml aprotinin, 5 μg/ml leupeptin, 5 μg/ml epstatin A, 5 μg/ml benzamidine, 12 μg/ml AEBSF [4-(2-aminoethyl)benzenesulfonyl fluoride]. Cells were broken up with an ice-cold Dounce homogenizer. After mild centrifugation (5 min at 500 g) to remove unbroken cells and the nuclei, the supernatant was ultracentrifuged at 100 000 g for 45 min at 4
• C. The pellet representing the membrane fraction and the supernatant representing the cytosolic fraction were resuspended in protein sample buffer.
Immunoprecipitation
Neutrophils were lysed in ice-cold lysis buffer [20 mM TrisHCl (pH 8.0), 137 mM NaCl, 2.7 mM KCl, 1 mM MgCl 2 , 1 mM CaCl 2 , 0.5% NP40, 10 % (v/v) glycerol, 0.5 mg/ml BSA, 1 mM Na 3 VO 4 , 1 mM PMSF, 21 μg/ml aprotinin, 12 μg/ml AEBSF, 5 μg/ml leupeptin, 5 μg/ml pepstatin A and 5 μg/ml benzamidine]. A cleared cell lysate were received by rapid centrifugation for 15 min at 4
• C. For immunoprecipitation, the lysates were preincubated with the appropriate antibodies for 2 h, before protein A sepharose beads were added for another 2 h. Finally, the beads were washed three times in ice-cold lysis buffer.
Immunoblotting
Equal amounts of proteins were separated by SDS-PAGE on 10 % polyacrylamide gels and subsequently transferred to polyvinylidene fluoride membranes. Blots were incubated in NET-G buffer [Tris/HCl (pH 8.0), 10 mM NaCl, 150 mM EDTA, 5 mM Tween-20 and 0.05 % (w/v) gelatin] for 1 h. Immunoblotting was performed using the indicated primary antibodies in NET-G buffer. After subsequent incubation with horseradish peroxidase-conjugated secondary antibody, the blots were quantitatively assayed using Western Lightning chemiluminescence detection (Perkin-Elmer Life Sciences, Boston, MA, U.S.A.) and a LAS3000 CCD camera (Fujifilm, Düsseldorf, Germany). Densitometric analysis of specific bands was used for the statistical analysis.
ROS production in neutrophils
Production of ROS was monitored using lucigenin-dependent chemiluminescence. Neutrophils were resuspended to a density of 1 × 10 6 cells/ml in buffer containing 200 μM lucigenin. Measurements were performed in triplicate at 37
• C [14] .
RESULTS

PI3Kγ associates with PKCα
Using a monoclonal antibody specific to the p110 catalytic subunit of PI3Kγ [8] , we initially produced immunoprecipitates from different cell types. Analyses of these precipitates by mass spectroscopy revealed numerous p110γ cell-specific interaction partners. The PI3Kγ immunoprecipitates obtained from human neutrophils were separated via SDS-PAGE. Copurified proteins were subsequently trypsin digested and identified by MS. In the 75-kDa molecular mass range, we identified peptides that originated from PKCα. In addition, we found indication for the association of matrix metalloproteinase 9, heat shock protein 70 and the α subunit of heterotrimeric G i proteins to the immunoprecipitated complex. To validate the interaction of PI3Kγ with PKCα, we analysed immunoprecipitates of PI3Kγ by Western blotting for the presence of PKCα ( Figure 1A ). These data revealed that PKCα was a specific interaction partner of PI3Kγ in human neutrophils. In order to validate the interaction of PI3Kγ and PKCα in vitro, identical amounts of His epitope-labelled recombinant PI3Kγ were incubated with GST epitope-labelled PKCα. Purification of the tagged proteins was carried out using Ni-NTA agarose beads for His-PI3Kγ and glutathione sepharose beads for GST- A whole-cell lysate was prepared and equal amounts of protein were immunoprecipitated with PI3Kγ antibody and immunoblotted with an antibody for PKCα. Antibodies against the above-mentioned proteins were precipitated with Protein A agarose beads, extensively washed, subjected to SDS-PAGE and blotted. Bait and co-bound proteins were analysed immunologically using specific antibodies (lane 1). To show non-specific binding, primary antibodies were replaced by non-specific IgG in a parallel sample (lane 2) IP, immunoprecipitate; WB, Western blot. (B) PI3Kγ and PKCα associate in vitro. Purified recombinant His-PI3Kγ and GST-PKCα protein (1 μg each) were incubated in 50 μl of protein kinase buffer for 30 min at room temperature. Complex formation was analysed using 50 μl of glutathione beads to purify GST-PKCα (PKCα pull down) or 50 μl of Ni-NTA beads to purify His-PI3Kγ (PI3Kγ pull down). After further incubation for 30 min, extensively washed beads were subjected to SDS-PAGE and blotted. Bait and co-bound proteins were analysed immunologically using specific antibodies. To show non-specific binding, bait proteins were omitted from a parallel sample as indicated. Representative data from experiments that were repeated several times are shown.
PKCα. As a control for non-specific binding to the column material, identical reaction mixtures were prepared excluding the corresponding bait proteins. While in the His-PI3Kγ pulldown experiment PKCα was efficiently copurified, in the absence of His-PI3Kγ only traces of GST-PKCα bound to the Ni-NTA agarose column. On the other hand, glutathione beads copurified His-PI3Kγ via GST-PKCα. Only traces of His-PI3Kγ could be detected if PKCα was omitted ( Figure 1B) , or if the GST epitope alone was used as a bait protein (results not shown). In another experiment, His-PI3Kγ and GST-PKCα were co-expressed in Sf9 insect cells. After 72 h, the cells were lysed and the cleared lysates were applied to GST-or Hisspecific pull-down assays. Essentially, the interaction profiles obtained were identical to those resulting from the biochemical studies described above (Supplementary Figure S1 at http://www. BiochemJ.org/bj/419/bj4190603add.htm). These results indicate that the association of PI3Kγ with PKCα is direct and specific.
PI3Kγ phosphorylates and stimulates PKCα in vitro
The direct binding of PI3Kγ to PKCα suggests that transphosphorylation reactions may occur between these signalling proteins. Both PKCα and PI3Kγ have been shown to exhibit protein kinase activities. Incubation of the recombinant proteins 32 P]ATP. As a control, the PKC inhibitor BIM (100 nM) or the PI3Kγ inhibitor wortmannin (WM, 100 nM) were added to the reaction mixture as indicated. Proteins were separated by SDS-PAGE.
32 P incorporated into GST-PKCα was detected and quantified by autoradiography using a phospho-imaging system. Representative data from experiments repeated three times are shown. Data are means + − S.D. Statistical significance was calculated using unpaired t-test; *P < 0.05; **P < 0.01. (B) Alignment of putative phosphorylation sites of PI3Kγ protein kinase activity. (C) Histone H1 is a specific substrate for PKCα. GST-PKCα or His-PI3Kγ (1 μg each) were incubated in 50 μl of protein kinase buffer containing the PKCα substrate histone H1 for 15 min at 37 • C in the presence of 2 μCi of [γ -32 P]ATP. Phosphorylation of histone H1 was monitored by separation via SDS-PAGE. 32 P incorporation into histone H1 was quantified by autoradiography using a phospho-imaging system. As controls, the PKC inhibitor BIM (100 nM) was added, or PI3Kγ was excluded from the reactions. The results are representative of three experiments. Quantification data are means + − S.D. (D) Specific activity of PKCα increases in the presence of PI3Kγ . GST-PKCα protein and His-PI3Kγ were incubated for 30 min at 37 • C in the presence of 30 μM ATP. Subsequently, the reaction mixture was diluted 6-fold, histone H1 and [γ -32 P]ATP were added, and samples were withdrawn at the indicated time points. Phosphorylation of histone H1 was analysed as described above. Representative data from experiments that were repeated several times are shown. Quantification data are means + − S.D. (E) p47phox is a substrate of PKCα. Purified p47phox, GST-PKCα, and His-PI3Kγ proteins were incubated at 37 • C in the presence of 30 μM ATP. Subsequently, the reaction mixture was diluted 6-fold, histone H1 and [γ -32 P]ATP were added, and samples were withdrawn at the indicated time points. Phosphorylation of p47phox was analysed as described above. Representative data from experiments that were repeated several times are shown. Quantification data are means + − S.D.
in the presence of [γ -32 P]ATP did not reveal PKCα-mediated phosphorylation of PI3Kγ (results not shown). In contrast, pronounced phosphorylation of PKCα by PI3Kγ could be demonstrated (Figure 2A ). To exclude auto-phosphorylation of the enzyme, PKCα activity was suppressed using BIM as an inhibitor of classical PKC species. Unaltered incorporation of 32 P confirmed PI3Kγ -mediated phosphorylation of the protein. Impaired phosphorylation of PKCα in the presence of the enzymatically inactive variant PI3Kγ -K799R or the PI3Kγ inhibitor wortmannin verified PI3Kγ -mediated transphosphorylation of PKCα (Figure 2A ). Activation of PKCα by other protein kinases, such as phosphoinositide-dependent kinase 1, has been described as involving the successive phosphorylation of amino-acid residues Thr 497 , Thr 638 and Ser 657 in the kinase domain [15, 16] . These target sites were analysed after PI3Kγ -mediated phosphorylation. Both recombinant proteins were incubated in the presence of nonradioactive ATP, and PKCα was repurified using SDS-PAGE, extracted from the polyacrylamide gel, trypsinized and subjected to MS. While the kinase reaction in the absence of PI3Kγ or ATP did not result in phosphorylated amino-acid residues, coincubation with PI3Kγ revealed peptides with specific mass shifts, suggesting the specific trans-phosphorylation of PKCα. Phosphorylation of serine or threonine residues could be identified at three different regions of the protein (Supplementary Figure  S2 at Figure S2 at http://www.BiochemJ.org/bj/419/bj4190603add.htm). These data confirm the serine-threonine kinase activities of PI3Kγ , and explore, for the first time to our knowledge, a specific site that is trans-phosphorylated by the enzyme.
The putative PI3Kγ -specific phosphorylation site of PKCα has some similarities to the auto-phosphorylation site of PI3Kγ , which was identified recently by Czupalla et al. [17] . As shown in Figure 2B , there is distinct homology between amino-acid residues 36-61 of PKCα and the auto-phosphorylation site located at the C-terminus of PI3Kγ . The resemblance between these two target sites for PI3Kγ protein kinase activity prompted us to search for further homology patterns in proteins that have been shown to act as substrates for PI3Kγ protein kinase. In recent reports, PI3Kγ -specific phosphorylations of MEK(MAPK/ERK kinase) [18] [19] [20] , p101 [20] , Ras [21] , 4EBP1 [21] and tropomyosin [22] were detected using recombinant proteins and cellular systems. Indeed, all of these PI3Kγ protein kinase substrates exhibit peptide sequences with different degrees of similarity to the PI3Kγ auto-phosphorylation site [17] and the transphosphorylation site in PKCα that was identified in the present study ( Figure 2B) .
After elucidating the binding and trans-phosphorylation of PKCα by PI3Kγ , we investigated the effects of the interaction of both signalling proteins on the specific activity of PKCα in vitro. The assay was carried out using histone H1 as a substrate, and PKCα kinase activity was monitored by incorporation of [γ -32 P]ATP-derived phosphate. While PI3Kγ alone did not phosphorylate histone H1, 32 P was efficiently incorporated in the presence of PKCα. This reaction could be specifically inhibited by addition of the PKC inhibitor BIM ( Figure 2C ). We next explored the effects of PI3Kγ on PKCα activity. As shown in Figure 2D , a pronounced stimulation of substrate phosphorylation was observed in the presence of PI3Kγ in a time range up to 20 min.
We further explored the NADPH oxidase components p47phox and p67phox as substrates in PKCα kinase assays. While p47phox was phosphorylated with similar efficiency to histone H1 ( Figure 2E ), phosphorylation of p67phox was only marginal (results not shown). Pre-incubation of PKCα with PI3Kγ induced only weak stimulation of p47phox phosphorylation compared with the kinase reaction in the absence of PI3Kγ .
fMLP induces PI3Kγ and PKCα complex formation in human neutrophils
To gain insight into the physiological role of the interactions between PI3Kγ and PKCα, we studied the complex formation of these proteins following stimulation of neutrophils with fMLP. PI3Kγ was immunoprecipitated at the indicated time points, and coprecipitated PKCα was assayed by Western blotting (Figure 3 ). The addition of fMLP markedly increased PKCα association with PI3Kγ in a transient manner ( Figure 3A) . In unstimulated neutrophils we did not observe any alteration in PKCα binding to the immunoprecipitate in the given period ( Figure 3B) . Remarkably, the p47phox subunit of NADPH oxidase associated with identical kinetics to this complex ( Figure 3A) . It has been demonstrated in different cellular systems that activation of both PI3Kγ and PKCα causes the association of these proteins with the plasma membrane [23, 24] . To correlate this process with the fMLP-induced interaction of the signalling proteins, we analysed the kinetics of membrane association after fMLP stimulation. The data shown in Figure 3(C) demonstrate that the distribution of both proteins was altered in response to fMLP stimulation. While PI3Kγ segregated to the membrane fraction, peaking after 120 s of stimulation, most PKCα molecules associated with membranes 60 s after fMLP treatment. These data reveal that the formation of fMLP-mediated PI3Kγ -PKCα complexes is a process paralleling the membrane association of these proteins.
fMLP induces PI3Kγ -mediated activation of PKCα
We next explored the functional relevance of the fMLP-induced association of PI3Kγ , PKCα and p47phox. Classical PKC species have been shown to stimulate NADPH oxidase activity via phosphorylation of p47phox [25] . However, the signalling reactions affecting PKC activity in neutrophils are poorly understood. Here, we first analysed specific PKCα activity in response to fMLP stimulation. Neutrophils were stimulated for the indicated time points, aliquots were withdrawn and lysed, and PKCα was immunoprecipitated. The protein kinase activity of PKCα was analysed by protein kinase assay using histone H1 as a substrate for 32 P incorporation. As shown in Figure 4A , specific PKCα kinase activity was markedly enhanced in response to neutrophil stimulation by fMLP. Maximum activity was reached 30 s after fMLP addition, which correlates with the onset of PI3Kγ -PKCα-p47phox complex formation.
To test the involvement of PI3Kγ enzymatic activity in the fMLP-dependent stimulation of PKCα, PKCα activity was analysed in cells treated with the specific PI3Kγ inhibitor AS605240 [26] . While the untreated cells corroborated the activity profile shown in Figure 4 (A), PKCα immunoprecipitated from neutrophils after treatment with AS605240 exhibited notably impaired PKC activity ( Figure 4B ). This observation points to a strict dependence of PKCα activity on functionally active PI3Kγ . To exclude non-specific effects of AS605240 on PKCα kinase activity, recombinant PKCα was pre-incubated with PI3Kγ inhibitors and subsequently assayed for its protein kinase activity in vitro. While treatment with the PKC inhibitor BIM completely abolished PKCα activity, neither wortmannin nor AS605240 significantly affected the enzymatic activity of PKCα ( Figure 4C ).
Enzymatic activities of PI3Kγ and PKCα control fMLP-dependent ROS production in neutrophils
A role for PI3Kγ in the production of ROS was elucidated in detail using specific inhibitors and PI3Kγ -deficient mice [27] . To study the involvement of PKCα in the control of oxidative bursts induced by fMLP, human neutrophils were treated with BIM, and the kinetics of ROS production were recorded. While the untreated cells showed the expected ROS induction profile after fMLP treatment, ROS production in BIM-pre-treated cells was severely diminished ( Figure 5 ). The PKC inhibitor Gö6976 applied at the same concentration showed essentially similar abrogation of ROS production (results not shown). PI3Kγ inhibition by AS605240 reduced fMLP-mediated ROS production to a degree similar to BIM. These data demonstrate the involvement of PKCα and PI3Kγ enzymatic activities in fMLP-mediated ROS induction.
DISCUSSION
There is an increasing amount of evidence indicating that the differential interactions of PI3Kγ with other signalling proteins depend upon the cell type [2, 24, 28] . Building upon these initial findings, we searched for PI3Kγ binding partners in different human cell types. MS of PI3Kγ immunoprecipitates obtained from human neutrophils revealed PKCα as a novel interaction partner of PI3Kγ . Analysis of PI3Kγ binding to PKCα in vitro clearly indicated the direct and specific association of these two signalling proteins. In addition, we demonstrated PKCα phosphorylation by PI3Kγ protein kinase activity. These results expand the list of substrates known to be phosphorylated by PI3Kγ protein kinase activity in vitro. In addition to substantial auto-phosphorylation activity, the current list includes trans-phosphorylation of MEK, p101, H-Ras and tropomyosin [10, [18] [19] [20] [21] [22] . In spite of preliminary data hinting at a regulatory function for the PI3Kγ protein kinase in cellular systems [19] , compelling evidence of a physiological role for this enzymatic activity is still missing.
Serine and threonine residues phosphorylated by PI3Kγ have been identified in three regions of PKCα. Interestingly, the most pronounced phosphorylation was found in a PKCα peptide localized in the second C1 domain of the DAG-binding domain of the protein. It shows significant homology to the C-terminal end of PI3Kγ , which has been identified as the autophosphorylation site [17] . Further similarities of this putative trans-phosphorylation site in PKCα to potential phosphorylation sites in other proteins such as MEK, p101, Ras, 4EBP1 and tropomyosin have been identified. All of these intracellular proteins have been found to act as substrates for PI3Kγ protein kinase activity [18] [19] [20] [21] [22] . The homology of the PKCα phosphorylation site to other known substrates suggests a widespread functional relevance of trans-phosphorylation reactions catalysed by PI3Kγ protein kinase activity.
In our study, the in vitro interactions of PKCα with PI3Kγ induced a marked increase in PKCα activity. Part of the stimulatory effect was observed after addition of a kinase-negative mutant of PI3Kγ , supporting the hypothesis that association with PI3Kγ directly augments PKCα activity. Together with our in vitro investigations, these data provide evidence of the direct and specific binding of PI3Kγ to PKCα, and identify PKCα as a potential substrate, whose enzymatic activity can be stimulated by phosphorylation triggered by PI3Kγ protein kinase activity. The possibility that immunoprecipitated PKCα contained additional proteins affecting total kinase activity cannot be excluded, but since 32 P incorporation in the PKCα substrate histone H1 was drastically abrogated in the presence of the PI3Kγ selective inhibitor AS605240, a specific PI3Kγ -mediated stimulation of PKCα activity can be concluded.
To explore the physiological function of PI3Kγ and PKCα interactions in human neutrophils, we stimulated the cells with the bacterial peptide fMLP. fMLP has been shown to affect both directed neutrophil migration and ROS production. Comparative investigations of neutrophils from PI3Kγ -deficient mice have demonstrated that both fMLP-dependent processes are mediated by PI3Kγ [4] [5] [6] . PKCα has been described as a mediator of fMLPinduced oxidative burst, and the regulatory subunit of NADPH oxidase p47phox was identified as an important target of PKCα activity [25] . The signalling pathway linking fMLP, the fMLP receptor and PKCα is poorly understood. Thus, our experimental data regarding the fMLP-dependent association of PKCα with PI3Kγ provide a first clue for signalling reactions that induce stimulation of PKCα activity by fMLP.
The fMLP-induced interaction between PI3Kγ and PKCα and the translocation of both proteins to the plasma membrane may contribute to the stimulation of PKCα activity observed after agonist addition. The PKCα substrate p47phox joins the complex with similar kinetics, possibly facilitating phosphorylation of this subunit and subsequent stimulation of NADPH oxidase. As shown by our inhibition experiments, PI3Kγ enzymatic activity is an essential mediator of fMLP-dependent stimulation of PKCα activity in neutrophils. Owing to the lack of specific inhibitors, these results do not allow for a definitive correlation of the blocking effect of AS605240 on PI3Kγ lipid or protein kinase activities. However, our findings showing PKCα phosphorylation Samples were withdrawn at the indicated time points, lysed and subjected to immunoprecipitation of PKCα. PKCα kinase activity was determined with SDS-PAGE and autoradiography using a phospho-imaging system to analyse 32 P incorporation into histone H1. Specific kinase activity was quantified as the ratio of 32 P incorporation to immunoprecipitated PKCα, as indicated in the graph. Results are means + − S.D. *Results are significantly different to untreated cells (P < 0.05). (B) Effects of PI3Kγ inhibitor on fMLP-dependent PKCα activity. Neutrophils were preincubated for 30 min at 37 • C in the presence or absence of the PI3Kγ -specific inhibitor AS605240 (10 μM) before stimulation with 1 μM fMLP. PKCα immunoprecipitation and quantification of specific PKCα kinase activity were performed as described above. IB, immunoblot. (C) AS605240 does not inhibit PKCα activity. In vitro-purified GST-PKCα (1 μg) was incubated in 50 μl of protein kinase buffer for 15 min at 37 • C in the presence of 2 μCi of [γ -
32 P]ATP in the presence of the PKC inhibitor BIM (Wm, 100 nM), the PI3Kγ inhibitor wortmannin (100 nM), or AS605240 at the indicated concentrations. Proteins were separated by SDS-PAGE.
32 P incorporated into histone H1 was detected and quantified by autoradiography using a phospho-imaging system. The data presented are representative of three experiments.
by PI3Kγ protein kinase in vitro, and the concomitant increase of PKCα activity, provide evidence for a lipid kinase-independent signalling reaction.
This conclusion may be in accordance with recent findings by Suire et al. [7] . These authors initially investigated the fMLPdependent synthesis of PtdIns(3,4,5)P 3 (the product of PI3Kγ lipid kinase activity) in p101-deficient mouse neutrophils. Compared with wild-type neutrophils, they observed a massive decrease in fMLP-sensitive PtdIns(3,4,5)P 3 synthesis, indicating an essential role for the p101 adapter protein in the control of PI3Kγ lipid kinase activity by G-protein-coupled receptors. As a second parameter, Suire et al. also performed comparative analysis of fMLP-dependent oxidative burst in wild-type and p101-deficient neutrophils [7] . Surprisingly, they did not observe any significant differences in ROS production indicating a marginal role for p101 in fMLP/PI3Kγ -dependent ROS production. Our investigations suggest the involvement of PI3Kγ protein kinase activity in the control of NADPH oxidase activity. They also provide evidence for a consecutive signalling path: fMLP → fMLP receptor → PI3Kγ protein kinase → PKCα → p47phox → NADPH-oxidase, which does not involve p101/p110γ -dependent PtdIns(3,4,5)P 3 production.
In fMLP-induced signalling pathways, PI3Kγ may act as a bifurcation point. Whereas PtdIns(3,4,5)P 3 produced by PI3Kγ lipid kinase activity controls the migration induced by chemoattractants, PI3Kγ protein kinase activity may affect the oxidative burst via phosphorylation and concomitant stimulation of PKCα. Hence, these findings provide additional evidence for the differential cell-specific regulatory functions of PI3Kγ . 
